**GlucoTrack (NASDAQ: GCTK) Approves Increase in Authorized Shares**WASHINGTON, D.C. 20549 – GlucoTrack, Inc. (NASDAQ: GCTK) reported on January 3, 2025, that they held a Special Meeting of its stockholders in which they approved an amendment to the

**

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GlucoTrack’s 8K filing here.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.